{"disease":{"id":"previously-treated-her2-negative-breast-cancer-patients-with-homologous-recombination-deficiency","name":"previously treated her2 negative breast cancer patients with homologous recombination deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07113964","title":"QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":79,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}